<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="10">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    https://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 16, 2016</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00828009</url>
  </required_header>
  <id_info>
    <org_study_id>CDR0000632611</org_study_id>
    <secondary_id>E6508</secondary_id>
    <nct_id>NCT00828009</nct_id>
  </id_info>
  <brief_title>BLP25 Liposome Vaccine and Bevacizumab After Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed Stage IIIA or Stage IIIB Non-Small Cell Lung Cancer That Cannot Be Removed by Surgery</brief_title>
  <official_title>A Phase II Study of L-BLP25 and Bevacizumab in Unresectable Stage IIIA and IIIB Non-Squamous Non-Small Cell Lung Cancer After Definitive Chemoradiation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Eastern Cooperative Oncology Group</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Cancer Institute (NCI)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>Eastern Cooperative Oncology Group</source>
  <oversight_info>
    <authority>United States: Food and Drug Administration</authority>
  </oversight_info>
  <brief_summary>
    <textblock>
      RATIONALE: Vaccines may help the body build an effective immune response to kill tumor
      cells. Monoclonal antibodies, such as bevacizumab, can block tumor growth in different ways.
      Some block the ability of tumor cells to grow and spread. Others find tumor cells and help
      kill them or carry tumor-killing substances to them. Drugs used in chemotherapy work in
      different ways to stop the growth of tumor cells, either by killing the cells or by stopping
      them from dividing. Radiation therapy uses high-energy x-rays to kill tumor cells. Giving
      vaccine therapy together with bevacizumab after chemotherapy and radiation therapy may kill
      more tumor cells.

      PURPOSE: This phase II trial is studying the side effects of giving BLP25 liposome vaccine
      together with bevacizumab after chemotherapy and radiation therapy in treating patients with
      newly diagnosed stage IIIA or stage IIIB non-small cell lung cancer that cannot be removed
      by surgery.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      OBJECTIVES:

      Primary

        -  To determine the safety of BLP25 liposome vaccine and bevacizumab after definitive
           chemoradiotherapy and consolidation chemotherapy in patients with newly diagnosed,
           unresectable stage IIIA or IIIB nonsquamous cell non-small cell lung cancer.

      Secondary

        -  To evaluate the overall survival and progression-free in patients treated with this
           regimen.

        -  To evaluate the toxicity of this regimen in these patients.

      OUTLINE: This is a multicenter study.

        -  Chemoradiotherapy: Patients receive paclitaxel IV over 1 hour and carboplatin IV over
           15-30 minutes once a week for 6 weeks. Patients also undergo concurrent definitive
           radiotherapy 5 days a week for 6½ weeks. Patients with complete response (CR), partial
           response (PR), or stable disease (SD) proceed to consolidation chemotherapy.

        -  Consolidation chemotherapy: Patients receive paclitaxel IV over 3 hours and carboplatin
           IV over 15-30 minutes on day 1. Treatment repeats every 21 days for 2 courses in the
           absence of disease progression or unacceptable toxicity. Patients with CR, PR, or SD
           proceed to maintenance therapy.

        -  Maintenance therapy: Patients receive a single dose of cyclophosphamide IV over 15-30
           minutes 3 days before the first dose of bevacizumab and BLP25 liposome vaccine.
           Patients then receive bevacizumab IV over 30-90 minutes on day 1 and BLP25 liposome
           vaccine subcutaneously on days 1, 8, and 15 of courses 1 and 2 and on day 1 of every
           other course beginning in course 4. Treatment repeats every 21 days for up to 34
           courses in the absence of disease progression or unacceptable toxicity.

      After completion of study treatment, patients are followed periodically for up to 5 years.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>December 2010</start_date>
  <primary_completion_date type="Anticipated">January 2016</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <study_design>Masking: Open Label, Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Safety</measure>
    <safety_issue>Yes</safety_issue>
  </primary_outcome>
  <secondary_outcome>
    <measure>Progression-free survival</measure>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Overall survival</measure>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">55</enrollment>
  <condition>Lung Cancer</condition>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>bevacizumab</intervention_name>
  </intervention>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>emepepimut-S</intervention_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>carboplatin</intervention_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>cyclophosphamide</intervention_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>paclitaxel</intervention_name>
  </intervention>
  <intervention>
    <intervention_type>Radiation</intervention_type>
    <intervention_name>radiation therapy</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        DISEASE CHARACTERISTICS:

          -  Histologically confirmed newly diagnosed nonsquamous cell non-small cell lung cancer
             (NSCLC), including the following subtypes:

               -  Adenocarcinoma

               -  Large cell undifferentiated

               -  Bronchoalveolar cell

               -  NSCLC, not otherwise specified

          -  Unresectable stage IIIA or stage IIIB disease

               -  Patients with stage IIIA disease with mediastinal lymph node enlargement between
                  1 cm and 2.0 cm on CT scan must have these nodes biopsied (pathologic
                  confirmation) to rule out resectability

               -  Metastases to contralateral mediastinal or supraclavicular nodes allowed

          -  Measurable or non-measurable disease, as defined by RECIST criteria

          -  No significant pleural effusion as defined by either of the following:

               -  Pleural effusion is seen on CT scan only (not seen on chest x-ray)

               -  Pleural effusion does not reaccumulate within 1 week after thoracentesis AND is
                  cytologically negative

          -  No CNS metastases by head CT scan or MRI within the past 4 weeks

        PATIENT CHARACTERISTICS:

          -  ECOG performance status 0-1

          -  WBC ≥ 4,000/mm³ OR ANC ≥ 2,000/mm³

          -  Platelet count ≥ 140,000/mm³

          -  Hemoglobin ≥ 9.0 g/dL

          -  Total bilirubin ≤ 1.5 mg/dL

          -  AST/ALT ≤ 2.5 times upper limit of normal

          -  Serum creatinine ≤ 1.5 mg/mL OR creatinine clearance ≥ 45 mL/min

          -  Urine protein:creatinine ratio &lt; 1.0 by urine dipstick OR &lt; 1 g of protein by 24-hour
             urine collection

          -  INR ≤ 1.5 OR ≤ 3.0 if patient is on therapeutic anticoagulation

          -  PTT normal

          -  Not pregnant or nursing

          -  Negative pregnancy test

          -  Fertile patients must use effective contraception before, during, and for ≥ 6 months
             after completion of bevacizumab

          -  No other active malignancies

          -  No known hepatitis B or C

          -  No ongoing (lasting &gt; 14 days) or active infection or ongoing (lasting &gt; 14 days)
             fever within the past 6 months

          -  No gross hemoptysis ≥ grade 2 (defined as ≥ ½ teaspoon of bright red blood per
             episode) within the past 3 months

               -  No pulmonary hemoptysis

                    -  Confirmed extrapulmonary hemoptysis allowed

          -  No bleeding ≥ grade 2 or any bleeding requiring intervention

          -  No history of bleeding diathesis or coagulopathy

          -  No cardiac dysfunction, including any of the following:

               -  Clinically significant cardiovascular disease

               -  Myocardial infarction within the past 6 months

               -  New York Heart Association class III-IV congestive heart failure

               -  Unstable angina pectoris

               -  Serious cardiac arrhythmia requiring medication within the past 4 weeks

               -  History of hypertensive crisis or hypertensive encephalopathy

               -  Stroke or transient ischemic attack within the past 6 months

               -  Peripheral vascular disease ≥ grade 2 within the past 6 months

          -  No abdominal fistula, gastrointestinal perforation, or intra-abdominal abscess within
             the past 6 months

          -  No psychiatric illness or social situation that would limit compliance with study
             requirements

          -  No history of uncontrolled hypertension (i.e., blood pressure ≥ 150/100 mm Hg) while
             on stable regimen of antihypertensive therapy

          -  No significant traumatic injury or serious non-healing wound, ulcer, or bone fracture
             within the past 4 weeks

          -  No recognized immunodeficiency disease, including cellular immunodeficiencies,
             hypogammaglobulinemia or dysgammaglobulinemia, or hereditary or congenital
             immunodeficiencies

          -  No pre-existing medical condition requiring chronic steroids or immunosuppressive
             therapy

          -  No autoimmune disease

          -  No known hypersensitivity to any component of bevacizumab

        PRIOR CONCURRENT THERAPY:

          -  See Disease Characteristics

          -  More than 4 weeks since prior open biopsy or major surgical procedure

          -  More than 28 days since prior immunotherapy (e.g., interferon, interleukin,
             sargramostim [GM-CSF], or filgrastim [G-CSF])

          -  Patients must not have had prior chemotherapy or monoclonal antibodies for other
             cancers within 5 years prior to registration

          -  More than 7 says since prior core biopsy or any other minor surgical procedure,
             excluding the placement of a vascular access device

          -  No prior chemotherapy for lung cancer

          -  No prior chest radiotherapy

          -  No prior splenectomy

          -  Concurrent stable regimen of therapeutic anticoagulation or prophylactic
             anticoagulation for venous access devices allowed provided coagulation studies met
             entry criteria

          -  No concurrent daily aspirin (&gt; 325 mg/day) or nonsteroidal anti-inflammatory agents
             (NSAIDs) known to inhibit platelet function

          -  No concurrent dipyridamole (Persantine), ticlopidine (Ticlid), clopidogrel bisulfate
             (Plavix), and/or cilostazol (Pletal)

          -  No concurrent major surgical procedure
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jyoti D. Patel</last_name>
    <role>Study Chair</role>
    <affiliation>Robert H. Lurie Cancer Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Veterans Affairs Medical Center - Palo Alto</name>
      <address>
        <city>Palo Alto</city>
        <state>California</state>
        <zip>94304</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Heather A. Wakelee</last_name>
      <phone>650-493-5000</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Stanford Cancer Center</name>
      <address>
        <city>Stanford</city>
        <state>California</state>
        <zip>94305-5824</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Clinical Trials Office - Stanford Cancer Center</last_name>
      <phone>650-498-7061</phone>
      <email>cctoffice@stanford.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Medical Center of Central Georgia</name>
      <address>
        <city>Macon</city>
        <state>Georgia</state>
        <zip>31208</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Frederick M. Schnell, MD, FACP</last_name>
      <phone>478-743-7068</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>St. Joseph Medical Center</name>
      <address>
        <city>Bloomington</city>
        <state>Illinois</state>
        <zip>61701</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>John W. Kugler, MD</last_name>
      <phone>309-243-3605</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Graham Hospital</name>
      <address>
        <city>Canton</city>
        <state>Illinois</state>
        <zip>61520</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>John W. Kugler, MD</last_name>
      <phone>309-243-3605</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Memorial Hospital</name>
      <address>
        <city>Carthage</city>
        <state>Illinois</state>
        <zip>62321</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>John W. Kugler, MD</last_name>
      <phone>309-243-3605</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Robert H. Lurie Comprehensive Cancer Center at Northwestern University</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60611-3013</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Clinical Trials Office - Robert H. Lurie Comprehensive Cancer</last_name>
      <phone>312-695-1301</phone>
      <email>cancer@northwestern.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hematology and Oncology Associates</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60611</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Clinical Trails Office - Hematology and Oncology Associates</last_name>
      <phone>312-695-1301</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Saint Joseph Hospital</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60657</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ira Oliff, MD</last_name>
      <phone>847-673-1999</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Decatur Memorial Hospital Cancer Care Institute</name>
      <address>
        <city>Decatur</city>
        <state>Illinois</state>
        <zip>62526</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Clinical Trials Office - Decatur Memorial Hospital Cancer Care</last_name>
      <phone>217-876-4750</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Eureka Community Hospital</name>
      <address>
        <city>Eureka</city>
        <state>Illinois</state>
        <zip>61530</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>John W. Kugler, MD</last_name>
      <phone>309-243-3605</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Galesburg Clinic, PC</name>
      <address>
        <city>Galesburg</city>
        <state>Illinois</state>
        <zip>61401</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>John W. Kugler, MD</last_name>
      <phone>309-243-3605</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Ingalls Cancer Care Center at Ingalls Memorial Hospital</name>
      <address>
        <city>Harvey</city>
        <state>Illinois</state>
        <zip>60426</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Clinical Trials Office - Ingalls Cancer Care Center at Ingalls</last_name>
      <phone>708-915-4673</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Mason District Hospital</name>
      <address>
        <city>Havana</city>
        <state>Illinois</state>
        <zip>62644</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>John W. Kugler, MD</last_name>
      <phone>309-243-3605</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Kellogg Cancer Care Center</name>
      <address>
        <city>Highland Park</city>
        <state>Illinois</state>
        <zip>60035</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jyoti D. Patel</last_name>
      <phone>312-695-4549</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hinsdale Hematology Oncology Associates</name>
      <address>
        <city>Hinsdale</city>
        <state>Illinois</state>
        <zip>60521</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Elyse C. Schneiderman, MD</last_name>
      <phone>630-654-1790</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Provena St. Mary's Regional Cancer Center - Kankakee</name>
      <address>
        <city>Kankakee</city>
        <state>Illinois</state>
        <zip>60901</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jyoti D. Patel</last_name>
      <phone>312-695-4549</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>North Shore Oncology and Hematology Associates, Limited - Libertyville</name>
      <address>
        <city>Libertyville</city>
        <state>Illinois</state>
        <zip>60048</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jyoti D. Patel</last_name>
      <phone>312-695-4549</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>McDonough District Hospital</name>
      <address>
        <city>Macomb</city>
        <state>Illinois</state>
        <zip>61455</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>John W. Kugler, MD</last_name>
      <phone>309-243-3605</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Trinity Cancer Center at Trinity Medical Center - 7th Street Campus</name>
      <address>
        <city>Moline</city>
        <state>Illinois</state>
        <zip>61265</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Costas L. Constantinou, MD</last_name>
      <phone>563-359-9876</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Cancer Care and Hematology Specialists of Chicagoland - Niles</name>
      <address>
        <city>Niles</city>
        <state>Illinois</state>
        <zip>60714</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jyoti D. Patel</last_name>
      <phone>312-695-4549</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>BroMenn Regional Medical Center</name>
      <address>
        <city>Normal</city>
        <state>Illinois</state>
        <zip>61761</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>John W. Kugler, MD</last_name>
      <phone>309-243-3605</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Community Cancer Center</name>
      <address>
        <city>Normal</city>
        <state>Illinois</state>
        <zip>61761</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>John W. Kugler, MD</last_name>
      <phone>309-243-3605</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Community Hospital of Ottawa</name>
      <address>
        <city>Ottawa</city>
        <state>Illinois</state>
        <zip>61350</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>John W. Kugler, MD</last_name>
      <phone>309-243-3605</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Cancer Treatment Center at Pekin Hospital</name>
      <address>
        <city>Pekin</city>
        <state>Illinois</state>
        <zip>61554</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>John W. Kugler, MD</last_name>
      <phone>309-243-3605</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Proctor Hospital</name>
      <address>
        <city>Peoria</city>
        <state>Illinois</state>
        <zip>61614</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>John W. Kugler, MD</last_name>
      <phone>309-243-3605</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>CCOP - Illinois Oncology Research Association</name>
      <address>
        <city>Peoria</city>
        <state>Illinois</state>
        <zip>61615</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>John W. Kugler, MD</last_name>
      <phone>309-243-3605</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Oncology Hematology Associates of Central Illinois, PC - Peoria</name>
      <address>
        <city>Peoria</city>
        <state>Illinois</state>
        <zip>61615</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>John W. Kugler, MD</last_name>
      <phone>309-243-3605</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Methodist Medical Center of Illinois</name>
      <address>
        <city>Peoria</city>
        <state>Illinois</state>
        <zip>61636</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Clinical Trials Office - Methodist Medical Center of Illinois</last_name>
      <phone>309-243-3000</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>OSF St. Francis Medical Center</name>
      <address>
        <city>Peoria</city>
        <state>Illinois</state>
        <zip>61637</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>John W. Kugler, MD</last_name>
      <phone>309-243-3605</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Illinois Valley Community Hospital</name>
      <address>
        <city>Peru</city>
        <state>Illinois</state>
        <zip>61354</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>John W. Kugler, MD</last_name>
      <phone>309-243-3605</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Perry Memorial Hospital</name>
      <address>
        <city>Princeton</city>
        <state>Illinois</state>
        <zip>61356</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>John W. Kugler, MD</last_name>
      <phone>309-243-3605</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Swedish-American Regional Cancer Center</name>
      <address>
        <city>Rockford</city>
        <state>Illinois</state>
        <zip>61104-2315</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Clinical Trials Office - Swedish-American Regional Cancer Cent</last_name>
      <phone>815-489-4413</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hematology Oncology Associates - Skokie</name>
      <address>
        <city>Skokie</city>
        <state>Illinois</state>
        <zip>60076</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jyoti D. Patel</last_name>
      <phone>312-695-4549</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Regional Cancer Center at Memorial Medical Center</name>
      <address>
        <city>Springfield</city>
        <state>Illinois</state>
        <zip>62781-0001</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Clinical Trials Office - Regional Cancer Center at Memorial Me</last_name>
      <phone>217-788-4233</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Elkhart General Hospital</name>
      <address>
        <city>Elkhart</city>
        <state>Indiana</state>
        <zip>46515</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jose A. Bufill, MD, FACP</last_name>
      <phone>574-234-5123</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Howard Community Hospital</name>
      <address>
        <city>Kokomo</city>
        <state>Indiana</state>
        <zip>46904</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jose A. Bufill, MD, FACP</last_name>
      <phone>574-234-5123</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Center for Cancer Therapy at LaPorte Hospital and Health Services</name>
      <address>
        <city>La Porte</city>
        <state>Indiana</state>
        <zip>46350</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jose A. Bufill, MD, FACP</last_name>
      <phone>574-234-5123</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Saint Joseph Regional Medical Center</name>
      <address>
        <city>Mishawaka</city>
        <state>Indiana</state>
        <zip>46545-1470</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jose A. Bufill, MD, FACP</last_name>
      <phone>574-234-5123</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Cancer Center at Ball Memorial Hospital</name>
      <address>
        <city>Muncie</city>
        <state>Indiana</state>
        <zip>47303-3499</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Clinical Trials Office - Cancer Center at Ball Memorial Hospit</last_name>
      <phone>765-281-2107</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>CCOP - Northern Indiana CR Consortium</name>
      <address>
        <city>South Bend</city>
        <state>Indiana</state>
        <zip>46601</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jose A. Bufill, MD, FACP</last_name>
      <phone>574-234-5123</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Memorial Hospital of South Bend</name>
      <address>
        <city>South Bend</city>
        <state>Indiana</state>
        <zip>46601</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Clinical Trials Office - Memorial Hospital of South Bend</last_name>
      <phone>800-284-7370</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>McFarland Clinic, PC</name>
      <address>
        <city>Ames</city>
        <state>Iowa</state>
        <zip>50010</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Clinical Trials Office - McFarland Clinic, PC</last_name>
      <phone>515-239-2621</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Medical Oncology and Hematology Associates - West Des Moines</name>
      <address>
        <city>Clive</city>
        <state>Iowa</state>
        <zip>50325</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Robert J. Behrens</last_name>
      <phone>515-875-9713</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>CCOP - Iowa Oncology Research Association</name>
      <address>
        <city>Des Moines</city>
        <state>Iowa</state>
        <zip>50309</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Robert J. Behrens</last_name>
      <phone>515-244-7586</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>John Stoddard Cancer Center at Iowa Methodist Medical Center</name>
      <address>
        <city>Des Moines</city>
        <state>Iowa</state>
        <zip>50309</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Clinical Trials Office - John Stoddard Cancer Center at Iowa M</last_name>
      <phone>515-241-6727</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Medical Oncology and Hematology Associates at John Stoddard Cancer Center</name>
      <address>
        <city>Des Moines</city>
        <state>Iowa</state>
        <zip>50309</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Robert J. Behrens</last_name>
      <phone>515-282-2921</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Medical Oncology and Hematology Associates at Mercy Cancer Center</name>
      <address>
        <city>Des Moines</city>
        <state>Iowa</state>
        <zip>50314</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Robert J. Behrens</last_name>
      <phone>515-643-8740</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Mercy Cancer Center at Mercy Medical Center - Des Moines</name>
      <address>
        <city>Des Moines</city>
        <state>Iowa</state>
        <zip>50314</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Robert J. Behrens</last_name>
      <phone>515-643-8206</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>John Stoddard Cancer Center at Iowa Lutheran Hospital</name>
      <address>
        <city>Des Moines</city>
        <state>Iowa</state>
        <zip>50316</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Clinical Trials Office - John Stoddard Cancer Center at Iowa L</last_name>
      <phone>515-241-8704</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Siouxland Hematology-Oncology Associates, LLP</name>
      <address>
        <city>Sioux City</city>
        <state>Iowa</state>
        <zip>51101</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Donald B. Wender, MD, PhD</last_name>
      <phone>712-252-0088</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Mercy Medical Center - Sioux City</name>
      <address>
        <city>Sioux City</city>
        <state>Iowa</state>
        <zip>51102</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Donald B. Wender, MD, PhD</last_name>
      <phone>712-252-0088</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>St. Luke's Regional Medical Center</name>
      <address>
        <city>Sioux City</city>
        <state>Iowa</state>
        <zip>51104</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Donald B. Wender, MD, PhD</last_name>
      <phone>712-252-0088</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Tufts Medical Center Cancer Center</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02111</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gary M. Strauss</last_name>
      <phone>617-636-6100</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Borgess Medical Center</name>
      <address>
        <city>Kalamazoo</city>
        <state>Michigan</state>
        <zip>49001</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Raymond S. Lord, MD</last_name>
      <phone>269-373-7458</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>West Michigan Cancer Center</name>
      <address>
        <city>Kalamazoo</city>
        <state>Michigan</state>
        <zip>49007-3731</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Clinical Trials Office - West Michigan Cancer Center</last_name>
      <phone>269-373-7458</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Bronson Methodist Hospital</name>
      <address>
        <city>Kalamazoo</city>
        <state>Michigan</state>
        <zip>49007</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Raymond S. Lord, MD</last_name>
      <phone>269-373-7458</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Lakeland Regional Cancer Care Center - St. Joseph</name>
      <address>
        <city>Saint Joseph</city>
        <state>Michigan</state>
        <zip>49085</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jose A. Bufill, MD, FACP</last_name>
      <phone>574-234-5123</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Lakeside Cancer Specialists, PLLC</name>
      <address>
        <city>Saint Joseph</city>
        <state>Michigan</state>
        <zip>49085</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jose A. Bufill, MD, FACP</last_name>
      <phone>574-234-5123</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Cancer Resource Center - Lincoln</name>
      <address>
        <city>Lincoln</city>
        <state>Nebraska</state>
        <zip>68510</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gamini S. Soori, MD, FACP, FRCP, MBA</last_name>
      <phone>402-393-3110</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>CCOP - Missouri Valley Cancer Consortium</name>
      <address>
        <city>Omaha</city>
        <state>Nebraska</state>
        <zip>68106</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gamini S. Soori, MD, FACP, FRCP, MBA</last_name>
      <phone>402-393-3110</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Immanuel Medical Center</name>
      <address>
        <city>Omaha</city>
        <state>Nebraska</state>
        <zip>68122</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gamini S. Soori, MD, FACP, FRCP, MBA</last_name>
      <phone>402-393-3110</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Alegant Health Cancer Center at Bergan Mercy Medical Center</name>
      <address>
        <city>Omaha</city>
        <state>Nebraska</state>
        <zip>68124</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Clinical Trials Office - Alegant Health Cancer Center at Berge</last_name>
      <phone>402-398-6060</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Lakeside Hospital</name>
      <address>
        <city>Omaha</city>
        <state>Nebraska</state>
        <zip>68130</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gamini S. Soori, MD, FACP, FRCP, MBA</last_name>
      <phone>402-393-3110</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Creighton University Medical Center</name>
      <address>
        <city>Omaha</city>
        <state>Nebraska</state>
        <zip>68131-2197</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Clinical Trials Office - Creighton University Medical Center</last_name>
      <phone>402-280-4100</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Cancer Institute of New Jersey at Hamilton</name>
      <address>
        <city>Hamilton</city>
        <state>New Jersey</state>
        <zip>08690</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Clinical Trials Office - Cancer Institute of New Jersey at Ham</last_name>
      <phone>609-631-6946</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Cancer Institute of New Jersey at UMDNJ - Robert Wood Johnson Medical School</name>
      <address>
        <city>New Brunswick</city>
        <state>New Jersey</state>
        <zip>08903</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Clinical Trials Office - Cancer Institute of New Jersey</last_name>
      <phone>732-235-8675</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Stony Brook University Cancer Center</name>
      <address>
        <city>Stony Brook</city>
        <state>New York</state>
        <zip>11794-9446</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Clinical Trials Office - Stony Brook University Cancer Center</last_name>
      <phone>800-862-2215</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Mercy Cancer Center at Mercy Medical Center</name>
      <address>
        <city>Canton</city>
        <state>Ohio</state>
        <zip>44708</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mitchell Haut, MD</last_name>
      <phone>330-453-9993</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Case Comprehensive Cancer Center</name>
      <address>
        <city>Cleveland</city>
        <state>Ohio</state>
        <zip>44106-5065</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Clinical Trials Office - Case Comprehensive Cancer Center</last_name>
      <phone>800-641-2422</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>St. Rita's Medical Center</name>
      <address>
        <city>Lima</city>
        <state>Ohio</state>
        <zip>45801</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Clinical Trials Office - St. Rita's Medical Center</last_name>
      <phone>419-226-9617</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Morgan Cancer Center at Lehigh Valley Hospital - Cedar Crest</name>
      <address>
        <city>Allentown</city>
        <state>Pennsylvania</state>
        <zip>18105</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Eliot L. Friedman, MD</last_name>
      <phone>610-402-0512</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Geisinger Cancer Institute at Geisinger Health</name>
      <address>
        <city>Danville</city>
        <state>Pennsylvania</state>
        <zip>17822-0001</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Clinical Trials Office - Geisinger Cancer Institute</last_name>
      <phone>570-271-5251</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>PinnacleHealth Regional Cancer Center at Polyclinic Hospital</name>
      <address>
        <city>Harrisburg</city>
        <state>Pennsylvania</state>
        <zip>17110-2098</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Oncology Clinical Trial Coordinator</last_name>
      <phone>717-782-4750</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Geisinger Hazleton Cancer Center</name>
      <address>
        <city>Hazleton</city>
        <state>Pennsylvania</state>
        <zip>18201</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Rajiv Panikkar</last_name>
      <phone>570-459-2901</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Penn State Hershey Cancer Institute at Milton S. Hershey Medical Center</name>
      <address>
        <city>Hershey</city>
        <state>Pennsylvania</state>
        <zip>17033-0850</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Clinical Trials Office - Penn State Hershey Cancer Institute a</last_name>
      <phone>717-531-3779</phone>
      <email>CTO@hmc.psu.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Lewistown Hospital</name>
      <address>
        <city>Lewistown</city>
        <state>Pennsylvania</state>
        <zip>17044</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Henry Wagner, MD</last_name>
      <phone>717-531-5471</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Pottstown Memorial Regional Cancer Center</name>
      <address>
        <city>Pottstown</city>
        <state>Pennsylvania</state>
        <zip>19464</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Wei Song, MD, PhD</last_name>
      <phone>610-327-7555</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Geisinger Medical Group - Scenery Park</name>
      <address>
        <city>State College</city>
        <state>Pennsylvania</state>
        <zip>16801</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Rajiv Panikkar</last_name>
      <phone>814-231-4560</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Mount Nittany Medical Center</name>
      <address>
        <city>State College</city>
        <state>Pennsylvania</state>
        <zip>16803</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Henry Wagner, MD</last_name>
      <phone>717-531-5471</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Frank M. and Dorothea Henry Cancer Center at Geisinger Wyoming Valley Medical Center</name>
      <address>
        <city>Wilkes-Barre</city>
        <state>Pennsylvania</state>
        <zip>18711</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Clinical Trials Office - Frank M. and Dorothea Henry Cancer Ce</last_name>
      <phone>570-271-5251</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Vanderbilt-Ingram Cancer Center</name>
      <address>
        <city>Nashville</city>
        <state>Tennessee</state>
        <zip>37232-6838</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Clinical Trials Office - Vanderbilt-Ingram Cancer Center</last_name>
      <phone>800-811-8480</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Parkland Memorial Hospital</name>
      <address>
        <city>Dallas</city>
        <state>Texas</state>
        <zip>75235</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Joan H. Schiller, MD</last_name>
      <phone>214-648-4180</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Simmons Comprehensive Cancer Center at University of Texas Southwestern Medical Center - Dallas</name>
      <address>
        <city>Dallas</city>
        <state>Texas</state>
        <zip>75390</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Clinical Trials Office - Simmons Comprehensive Cancer Center a</last_name>
      <phone>866-460-4673; 214-648-7097</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>West Virginia University Health Sciences Center - Charleston</name>
      <address>
        <city>Charleston</city>
        <state>West Virginia</state>
        <zip>25304</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Steven J. Jubelirer, MD</last_name>
      <phone>304-388-8380</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Gundersen Lutheran Center for Cancer and Blood</name>
      <address>
        <city>La Crosse</city>
        <state>Wisconsin</state>
        <zip>54601</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Clinical Trials Office - Gundersen Lutheran Cancer Center</last_name>
      <phone>608-775-2385</phone>
      <email>cancerctr@gundluth.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Regional Cancer Center at Oconomowoc Memorial Hospital</name>
      <address>
        <city>Oconomowoc</city>
        <state>Wisconsin</state>
        <zip>53066</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Clinical Trials Office - Regional Cancer Center at Oconomowoc</last_name>
      <phone>262-928-7878</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Waukesha Memorial Hospital Regional Cancer Center</name>
      <address>
        <city>Waukesha</city>
        <state>Wisconsin</state>
        <zip>53188</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Clinical Trials Office - Waukesha Memorial Hospital Regional C</last_name>
      <phone>262-928-7632</phone>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>September 2014</verification_date>
  <lastchanged_date>September 16, 2014</lastchanged_date>
  <firstreceived_date>January 22, 2009</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>stage IIIA non-small cell lung cancer</keyword>
  <keyword>stage IIIB non-small cell lung cancer</keyword>
  <keyword>adenocarcinoma of the lung</keyword>
  <keyword>bronchoalveolar cell lung cancer</keyword>
  <keyword>large cell lung cancer</keyword>
  <is_fda_regulated>Yes</is_fda_regulated>
  <is_section_801>Yes</is_section_801>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Carcinoma, Non-Small-Cell Lung</mesh_term>
    <mesh_term>Lung Neoplasms</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Bevacizumab</mesh_term>
    <mesh_term>Cyclophosphamide</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
